| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | Christopher Rovaldi | Chief Operating Officer | Apr 06, 2022 | Option/RSU Exercise | $16.00 | 1,728 | 27,648 | 1,728 | Apr 08, 2022, 04:21 PM | |
| KROS | Keros Therapeutics, Inc. | Christopher Rovaldi | Chief Operating Officer | Apr 06, 2022 | Sale | $65.00 | 1,728 | 112,320 | 0 | Apr 08, 2022, 04:21 PM | |
| KROS | Keros Therapeutics, Inc. | Christopher Rovaldi | Chief Operating Officer | Apr 01, 2022 | Option/RSU Exercise | $16.00 | 864 | 13,824 | 864 | Apr 05, 2022, 04:31 PM | |
| KROS | Keros Therapeutics, Inc. | Christopher Rovaldi | Chief Operating Officer | Apr 01, 2022 | Sale | $57.49 | 864 | 49,675 | 862 | Apr 05, 2022, 04:31 PM |